Compare iShares MSCI Indonesia ETF (EIDO) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Indonesia ETF vs Select Medical Holdings Corporation — how do they compare? iShares MSCI Indonesia ETF trades at $12.22, while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Select Medical Holdings Corporation pays a 1.51% dividend while iShares MSCI Indonesia ETF pays none, and Select Medical Holdings Corporation is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| EIDO | SEM | |
|---|---|---|
52-Week High | $19.22 | $16.66 |
52-Week Low | $10.80 | $11.77 |
Market Cap | — | $2.05B |
Sector | — | Health |
Enterprise Value | — | $5.01B |
Dividend Yield | — | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Indonesia ETF (EIDO) trades at $12.20, up 1.08% on the day, while technical indicators signal a bearish trend with moving averages and overall signals in sell territory. Recent news highlights Indonesia's economic initiatives, including a $15 billion AI-integrated free-meal program and central bank rate hikes to support the rupiah, which directly impacts this country-focused ETF. The fund's dividend was reported to have dropped 27% in 2025, raising questions about underlying asset performance.
The outlook for EIDO is tied to Indonesia's macroeconomic stability and government policy execution. Investment opportunity lies in exposure to Indonesia's growth initiatives, but risks include currency volatility from Bank Indonesia's defensive actions, geopolitical pressures on emerging markets, and the ETF's high-yield but potentially unstable dividend profile.
Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, with a mixed technical picture showing bullish oscillators but bearish moving averages. Recent earnings show volatility with Q3 2025 beating estimates but Q1 2026 missing, while valuation ratios like P/E of 15.43 and P/S of 0.36 suggest moderate pricing. The company announced a $0.06 dividend for H1 2026, but news highlights its acquisition completion by a consortium led by Robert A. Ortenzio in June 2026, with legal investigations into the fairness of the $16.50 per share deal.
The outlook is clouded by acquisition-related uncertainties and legal scrutiny, posing risks to shareholder value. Analyst consensus leans neutral with 57.15% hold ratings, reflecting cautious sentiment amid the takeover. Investors should weigh the stable fundamentals against potential dilution or litigation outcomes, with the stock's near-term direction tied to resolution of these corporate actions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
